Get the Stockscreener App
4.90
0.41%
0.02
After Hours:
4.90
Dna X Inc stock is traded at $4.90, with a volume of 11,008.
It is up +0.41% in the last 24 hours and up +34.99% over the past month.
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
See More
Previous Close:
$4.88
Open:
$4.51
24h Volume:
11,008
Relative Volume:
0.26
Market Cap:
$7.29M
Revenue:
$59.11M
Net Income/Loss:
$-33.38M
P/E Ratio:
-0.0274
EPS:
-178.995
Net Cash Flow:
$-26.04M
1W Performance:
+16.95%
1M Performance:
+34.99%
6M Performance:
-57.61%
1Y Performance:
-80.83%
1-Day Range:
$4.51
$4.985
1-Week Range:
$4.25
$5.4499
52-Week Range:
$2.5211
$38.52
Dna X Inc Stock (SONM) Company Profile
Name
Dna X Inc
Sector
Industry
Phone
650-378-8100
Address
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
4.90 | 7.26M | 59.11M | -33.38M | -26.04M | -179.00 |
MSFT
Microsoft Corp
|
411.38 | 3.07T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
185.35 | 518.52B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
135.91 | 350.06B | 5.22B | 2.29B | 2.69B | 0.889 |
CRWD
Crowdstrike Holdings Inc
|
476.53 | 119.01B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
502.51 | 95.30B | 8.00B | 1.10B | 2.28B | 6.4708 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-19 | Initiated | B. Riley FBR | Buy |
| Jul-09-19 | Upgrade | National Securities | Neutral → Buy |
| Jun-10-19 | Initiated | National Securities | Neutral |
| Jun-04-19 | Initiated | Lake Street | Buy |
| Jun-04-19 | Initiated | Oppenheimer | Outperform |
View All
Dna X Inc Stock (SONM) Latest News
Central Bancompany, Inc. Announces Dividend Declaration and Reports May 2026 SEC Filing Results - Minichart
How DNA's Double Helix Structure Was Discovered - Britannica
SONM Forecast, Price Target & Analyst Ratings | DNA X INC (NASDAQ:SONM) - ChartMill
[10-K/A] DNA X, Inc. Amends Annual Report - Stock Titan
[8-K] DNA X, Inc. Reports Material Event - Stock Titan
Ginkgo Bioworks will take investor questions after May 7 results - Stock Titan
Ansa Biotechnologies to Showcase Breakthrough DNA Synthesis Technology Backed by Industry’s Only On-Time Guarantee at SynBioBeta 2026 Conference - 01net
Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine - Business Wire
SONM Stock Price, Quote & Chart | DNA X INC (NASDAQ:SONM) - ChartMill
SONM Price Today: DNA X, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
INSP (Inspire Medical Systems Inc.) Q4 2025 EPS beats estimates by wide margin even as shares dip slightly today. - Cổng thông tin điện tử tỉnh Lào Cai
SONM (DNA X) tops Q3 2024 EPS forecasts, lifting shares nearly 10 percent on positive investor sentiment.Management Guidance - Cổng thông tin điện tử tỉnh Lào Cai
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - 富途牛牛
12 Information Technology Stocks Moving In Wednesday's After-Market Session - Benzinga
DNA X, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
DNA X, Inc. Reports 2025 Financial Results, Completes Asset Sale, and Focuses on Growth of Cryptocurrency Trading Platform - Minichart
DNA X (NASDAQ: SONM) outlines crypto shift, tiny scale and going‑concern risk - Stock Titan
Global Experts Face-to-Face Interview Series – Redefining Yunnan’s Strategic Value - businessnewsthisweek.com
DNA X, Inc. Reports Full Year 2025 Financial Results - Scott Coop
DNA X sold its phone business for $15M to focus on crypto trading - Stock Titan
DNA X (NASDAQ: SONM) narrows 2025 loss and sells mobile unit to fund crypto pivot - Stock Titan
Earnings Report: Will Applied DNA Sciences Inc outperform its industry peersTrade Entry Report & Smart Allocation Stock Reports - baoquankhu1.vn
Tax-driven share sales follow PSU vesting at Ginkgo Bioworks (DNA) - Stock Titan
Restriction-enzyme DNA fingerprinting method explained - Britannica
NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test - The Manila Times
DNA X : News Release - marketscreener.com
Non-controlling/minority interest of DNA X, Inc. – MUN:J6P - TradingView
Power DNA x Lain: Okori enerugî (Music Video 2017)News - IMDb
DNA X, Inc. delays 2025 annual filing - The Globe and Mail
Dna X Inc. Live Share Prices and Trades. SONM.US Live Streaming Share Prices. - London South East
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session - Benzinga
[NT 10-K] DNA X, Inc. SEC Filing - Stock Titan
Ansa Biotechnologies Appoints Matthias Arenskötter as Chief Operating Officer - Business Wire
12 Information Technology Stocks Moving In Monday's Intraday SessionAmplitech Group, Inc.Series A R - Benzinga
Broadbent & Associates, Inc. receives Nevada Gold Mines ‘Results Driven’ DNA award - Northern Nevada Business Weekly
Feel Good Inc. X DNA. (Mashup) [1e740c] - Fathom Journal
DNA X (SONM) Surges 21.9% on Intraday Spike—What’s Behind the Volatility? - Bitget
The latest Star Wars Zero Company details tease Mass Effect DNA, hardcore turn-based tactics, permadeath, and new Clone Wars lore - Eurogamer.net
New liquid biopsy from VolitionRx finds 49 of 49 cancers in early study - Stock Titan
Dna Holdings Venture Inc. Net Worth (2026) - GuruFocus
How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And Risk - Yahoo Finance
Illumina Inc.: Why This DNA Giant Just Got Way More Interesting for You - AD HOC NEWS
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
Equity in earnings of DNA X, Inc. – MUN:J6P - TradingView
Hitachi's DNA on Display at Its Birthplace Why the Company's Origin Park Matters as It Globalizes - 東洋経済オンライン
DNA Brands, Inc. (DNAX) Competitors - Meyka
SONM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript - insidermonkey.com
DNA X (NASDAQ: SONM) revises view of DNA X LLC acquisition - Stock Titan
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How do XX and XY Chromosomes Determine Biological Sex? - Britannica
Dna X Inc Stock (SONM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):